000020 — Dongwha Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual income statement for Dongwha Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	293,018	340,426	361,109	464,875	496,394
Cost of Revenue
Gross Profit	149,347	180,990	190,416	214,258	218,547
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	270,732	313,989	342,825	451,866	495,648
Operating Profit	22,286	26,437	18,284	13,009	746
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26,527	23,086	36,956	6,902	6,003
Provision for Income Taxes
Net Income After Taxes	19,583	21,591	28,237	2,146	3,842
Minority Interest
Net Income Before Extraordinary Items
Net Income	17,870	20,383	27,438	5,563	8,686
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	17,870	20,383	27,438	5,563	8,686
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	648	847	1,004	210	90.6
Dividends per Share